Data as of Apr 17
| -3.40 / -1.13%|
The 19 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 348.00, with a high estimate of 410.00 and a low estimate of 276.00. The median estimate represents a +17.27% increase from the last price of 296.74.
The current consensus among 20 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.